Gregory Colman, MD
Dermatology · Santa Monica, CANPI 1003884925
Payments from drug & device makers
Across 103 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$385
- Johnson & Johnson$221
- Galderma Laboratories, L.p.$191
- Novartis$176
- Sanofi$172
- Sun Pharmaceutical Industries Inc.$153
- plus $940 from 19 others
What the payments were for
- Food & beverage$2,240100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $385 |
| Johnson & Johnson | 11 | $221 |
| Galderma Laboratories, L.p. | 9 | $191 |
| Novartis | 9 | $176 |
| Sanofi | 7 | $172 |
| Sun Pharmaceutical Industries Inc. | 7 | $153 |
| UCB, Inc. | 6 | $153 |
| Regeneron Healthcare Solutions, Inc. | 5 | $145 |
| Sandoz | 5 | $106 |
| LEO Pharma Inc. | 3 | $75 |
| E.r. Squibb & Sons, L.L.C. | 2 | $58 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $51 |
| EPI Health, LLC | 3 | $48 |
| Incyte Corporation | 2 | $45 |
| VYNE Pharmaceuticals Inc. | 2 | $41 |
| Amgen | 2 | $31 |
| Organon | 1 | $31 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Almirall LLC | 1 | $21 |
| Mission Pharmacal Company | 1 | $19 |
| Bristol Myers Squibb | 1 | $19 |
| Pfizer | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Smith+Nephew | 1 | $13 |
How this compares
$2,240 in reported general payments places this provider in the 50th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva HandihalerTiotropium Bromide | 11 | $5,541 |
| Fluorouracil | 23 | $1,463 |
| Fluocinonide | 58 | $1,345 |
| Clobetasol Propionate | 28 | $1,112 |
| Ketoconazole | 35 | $477 |
| Doxycycline Hyclate | 35 | $413 |
| Betamethasone Dipropionate | 14 | $380 |
| Metronidazole | 12 | $363 |
| ValacyclovirValacyclovir Hcl | 14 | $330 |
| Terbinafine Hcl | 29 | $330 |
| Imiquimod | 12 | $221 |
| Triamcinolone Acetonide | 29 | $189 |
| Spironolactone | 11 | $86 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Santa Monica
- Paul YamauchiSanta Monica$7.8M
- David StollSanta Monica$2.3M
- Ava ShambanSanta Monica$1.5M
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.